A Study of HS-10516 in Patients With Advanced Clear Cell Renal Cell Carcinoma
Condition: Renal Cell Carcinoma Intervention: Drug: HS-10516 Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials